跳至主要内容
临床试验/JPRN-UMIN000024236
JPRN-UMIN000024236已完成未知

Examination study of the gastroesophageal reflux disease improvement effect by Vonoprazan to the patients with systemic sclerosis - Effect of Vonoprazan to gastroesophageal reflux disease with systemic sclerosis

Department of Gastroenterology Nagasaki University Hospital0 个研究点目标入组 20 人开始时间: 2016年10月8日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Liver and kidney dysfunction 2. Allergy to many kind of drugs. 3. Pregnant or who have a possibility to pregnancy, and under nursing patient. 4. Participation to other study in 4 months. 5. The study patient who decided to inadequacy by person in charge. 6. Administration of atazanavir sulfate and rilpivirin hydrochloryde. 7. Severe allergy or complication history of vonoprazan.

研究者

发起方
Department of Gastroenterology Nagasaki University Hospital

相似试验